Milan Hora (@milanhoraplzen) 's Twitter Profile
Milan Hora

@milanhoraplzen

University Hospital @FNPlzen, CZ, head of @Urology_Plzen, @CUS_CLS_JEP - vice-chairman, @Czechurology - editor-in-chief, RCC guidelines panel @Uroweb - member

ID: 2844648361

linkhttp://urol.fnplzen.cz/ calendar_today07-10-2014 20:16:19

1,1K Tweet

1,1K Followers

675 Following

Esther Garcia Rojo (@rojo_esther) 's Twitter Profile Photo

Successfully performed onco-TESE in a young azoospermic patient with high FSH, testicular atrophy, and suspected neoplasia. The procedure led to the successful retrieval of motile sperm for ICSI. Great teamwork between urology and fertility teams. ROC Clinic HM HOSPITALES

Milan Hora (@milanhoraplzen) 's Twitter Profile Photo

Evaluation and Management of Retroperitoneal Masses in Patients with Testicular Cancer, pubmed.ncbi.nlm.nih.gov/39098447/ Eur Urol Focus Btw. FDG PET CT indicated only in residual mass in seminoma

Evaluation and Management of Retroperitoneal Masses in Patients with Testicular Cancer, pubmed.ncbi.nlm.nih.gov/39098447/ <a href="/EurUrolFocus/">Eur Urol Focus</a> Btw. FDG PET CT indicated only in residual mass in seminoma
Milan Hora (@milanhoraplzen) 's Twitter Profile Photo

Save the date 25.-26.4.2025 for next meeting of urologists from central Europe #CEM25. The last one organised in CZ was 2017 in Plzeň #CEM17. cem25.com #uroczech Btw. it is combined with Czech meeting 24.4. #JEUS25

Save the date 25.-26.4.2025 for next meeting of urologists from central Europe #CEM25. The last one organised in CZ  was 2017 in Plzeň #CEM17. cem25.com #uroczech Btw. it is combined with Czech meeting 24.4. #JEUS25
Czech urology (@czechurology) 's Twitter Profile Photo

Poslední letošní číslo 4-2024 je na světě. czechurol.cz/magno/cur/2024… Mj. jak řešit chylózní ascites po LAE, PEK (PCNL) na zádech, perzistující urachus, budoucnost robotiky, markery C61 v moči, o konferenci #CUS24 v Brně, nejlepší publikace 2023 #uroczech ČUS #uroczech

Poslední letošní číslo 4-2024 je na  světě. czechurol.cz/magno/cur/2024… Mj.  jak řešit chylózní ascites po LAE, PEK (PCNL) na zádech, perzistující urachus, budoucnost robotiky, markery C61 v moči, o konferenci #CUS24 v Brně, nejlepší publikace 2023 #uroczech <a href="/CUS_CLS_JEP/">ČUS #uroczech</a>
Milan Hora (@milanhoraplzen) 's Twitter Profile Photo

Adjuvant Pembrolizumab vs Observation in Muscle-Invasive Urothelial Carcinoma after radical surgery, disease-free survival 29.6 vs 14.2 months, hazard ratio for disease progression / death 0.73; AMBASSADOR trial, N Engl J Med. 2025 Jan 2;392(1):45-55 pubmed.ncbi.nlm.nih.gov/39282902/

Adjuvant Pembrolizumab vs Observation in Muscle-Invasive Urothelial Carcinoma after radical surgery, disease-free survival  29.6 vs 14.2 months, hazard ratio for disease progression / death 0.73; AMBASSADOR trial, N Engl J Med. 2025 Jan 2;392(1):45-55  pubmed.ncbi.nlm.nih.gov/39282902/
Milan Hora (@milanhoraplzen) 's Twitter Profile Photo

Updated European Association of Urology (EAU) #EAUguidelines on the Use of Adjuvant Immune Checkpoint Inhibitors and Subsequent Therapy for #RCC. Early or intermediate recurrence after adjuvant pembrolizumab should be treated with TKI monotherapy at systemic relapse doi.org/10.1016/j.euru…

Updated <a href="/Uroweb/">European Association of Urology (EAU)</a> #EAUguidelines on the Use of Adjuvant Immune Checkpoint Inhibitors and Subsequent Therapy for #RCC. Early or intermediate recurrence after adjuvant pembrolizumab should be treated with TKI monotherapy at systemic relapse doi.org/10.1016/j.euru…
Jura Háček 🇨🇿🇪🇺🇺🇦 (jirka maso :) (@jura_haczek) 's Twitter Profile Photo

Ježiš jak já nutně potřeboval vidět něco takovýho! Už to jinak začínalo vypadat, že snad Američanům hráblo komplet a bojí se ozvat, ale oni se taky jen probírají ze šoku, že je řídí retardi. Mike Myers by měl za toho Elona dostat okamžitě večer Oskara! 😂

Milan Hora (@milanhoraplzen) 's Twitter Profile Photo

#EAUguidelines on #RCC 2025 just published. Full version on European Association of Urology (EAU) web pages uroweb.org/guidelines/ren…, review as article of European Urology authors.elsevier.com/c/1ko5314kpm0h… #uroczech

#EAUguidelines on #RCC 2025 just published. Full version on <a href="/Uroweb/">European Association of Urology (EAU)</a> web pages uroweb.org/guidelines/ren…, review as article of <a href="/EUplatinum/">European Urology</a> authors.elsevier.com/c/1ko5314kpm0h… #uroczech
Czech urology (@czechurology) 's Twitter Profile Photo

První číslo Czech urology s novým nakladatelem Care Comm carecomm.cz je na světě. czechurol.cz/en/magno/cur/2… Robotická resekce tumoru ledviny, hernie u Brickera, hyperprolaktinemie u ED, cytologie moče u nádorů horních cest močových... ČUS #uroczech #uroczech

První číslo <a href="/CzechUrology/">Czech urology</a> s novým nakladatelem Care Comm carecomm.cz je na světě. czechurol.cz/en/magno/cur/2…
 Robotická resekce tumoru ledviny, hernie u Brickera, hyperprolaktinemie u ED, cytologie moče u nádorů horních cest močových... <a href="/CUS_CLS_JEP/">ČUS #uroczech</a> #uroczech
Milan Hora (@milanhoraplzen) 's Twitter Profile Photo

The best outcomes of kidney tumour resections are observed for patients treated at higher-volume hospitals. Is it time to change the ČUS #uroczech rules for CZ? #uroczech pubmed.ncbi.nlm.nih.gov/40210551/

The best outcomes of kidney tumour resections are observed for patients treated at higher-volume hospitals. Is it time to change the <a href="/CUS_CLS_JEP/">ČUS #uroczech</a> rules for CZ?  #uroczech pubmed.ncbi.nlm.nih.gov/40210551/
Milan Hora (@milanhoraplzen) 's Twitter Profile Photo

7 years after the publication of the CARMENA study, we are back. Not only Deferred but even Upfront Cytoreductive Nephrectomy is making a comeback. For clinical practice: #mRCC with favourable prognostic factors - Upfront CRNE followed with immunotherapy. pubmed.ncbi.nlm.nih.gov/40221280/

7 years after the publication of the CARMENA study, we are back. Not only Deferred but even Upfront Cytoreductive Nephrectomy is making a comeback. For clinical practice: #mRCC with favourable prognostic factors - Upfront CRNE followed with immunotherapy. pubmed.ncbi.nlm.nih.gov/40221280/